TB Advocates, Organizations Seek To Implement Funding Targets, Create More Innovative Finance Mechanisms

Devex: Advocates to seek TB funding targets at 2018 high-level meeting
“Global tuberculosis experts want to see numerical funding targets for combating the epidemic set at the first United Nations high-level meeting on the disease next year. Experts want to set additional targets for 2020 and 2025 linked with the World Health Organization’s End TB Strategy, as well as a corresponding accountability mechanism. … Advocates are seeking a commitment to hold a high-level meeting on TB every four years…” (Cousins, 10/18).

Devex: Q&A: Global TB efforts turn to innovative finance
“…The Global Fund to Fight AIDS, Tuberculosis and Malaria and the International Union against Tuberculosis and Lung Disease (The Union) last week announced a new partnership to spur investment among the private sector to help end the TB epidemic by 2030. … [T]he Global Fund, along with partners including the World Health Organization and Stop TB Partnership, last week also launched a new ‘catalytic funding’ program to find and treat an additional 1.5 million ‘missing’ people with TB in 13 high-burden countries by 2019. … Devex sat down with Dr. Christoph Benn, director of external relations at the Global Fund, to discuss the two new initiatives and what they will mean for combating the disease…” (Cousins, 10/18).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.